Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing bridging drug therapy approaches prior to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a prospective analysis from the national UK CURATE registry.

Open heart·2026
Same author

Coronary sinus reducer implantation for refractory angina: a national audit of UK practice.

Heart (British Cardiac Society)·2026
Same author

Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention.

The New England journal of medicine·2026
Same author

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial.

Nature medicine·2026
Same author

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

ERJ open research·2025
Same author

Artificial Intelligence-Led Whole Coronary Artery OCT Analysis; Validation and Identification of Drug Efficacy and Higher-Risk Plaques.

Circulation. Cardiovascular imaging·2025

Related Experiment Video

Updated: Jun 12, 2026

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.

Patrick M Heck1, Stephen P Hoole, Sadia N Khan

  • 1Cardiovascular Medicine, ACCI, Level 6, Box 110, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.

Cardiovascular Diabetology
|June 26, 2010
PubMed
Summary

Metabolic manipulation using a hyperinsulinemic euglycemic clamp (HEC) improved left ventricular (LV) function during stress tests in patients with coronary artery disease and insulin resistance (IR). This approach enhances myocardial glucose utilization, offering a promising therapeutic strategy for IR.

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Area of Science:

  • Cardiology
  • Metabolic Research
  • Cardiovascular Physiology

Background:

  • Glucose is a more efficient energy source than free fatty acids (FFA) for ATP production.
  • Insulin resistance (IR) is associated with elevated FFA levels and reduced myocardial glucose uptake, potentially exacerbating ischemic conditions.
  • Left ventricular (LV) function may be compromised in patients with IR under stress.

Purpose of the Study:

  • To investigate the impact of metabolic manipulation via hyperinsulinemic euglycemic clamp (HEC) on LV performance during dobutamine stress echocardiography (DSE).
  • To determine if HEC improves LV function in patients with coronary artery disease (CAD) and IR.
  • To compare the effects of HEC on LV function between insulin-sensitive (IS) and insulin-resistant (IR) groups.

Main Methods:

  • 24 subjects with normal LV function and CAD underwent two DSEs.
  • One DSE was preceded by HEC, involving insulin infusion and variable dextrose to maintain euglycemia.
  • LV function was assessed using tissue Doppler imaging to measure peak systolic velocities (Vs) and LV ejection fraction (EF) at each stress stage.

Main Results:

  • HEC successfully suppressed FFAs and increased myocardial glucose utilization.
  • LV performance significantly improved post-HEC, evidenced by increased EF and peak Vs in ischemic segments.
  • The improvement in LV function was more pronounced in the IR group compared to the IS group.

Conclusions:

  • Hyperinsulinemic euglycemic clamp-induced increase in myocardial glucose use enhances LV function under stress in patients with CAD and IR.
  • Targeting cardiac metabolism in individuals with IR presents a potential therapeutic avenue.
  • Metabolic modulation strategies may be beneficial for improving cardiac function in at-risk populations.